Phio Pharmaceuticals (PHIO) EPS (Basic) (2011 - 2026)
Phio Pharmaceuticals' (PHIO) quarterly EPS (Basic) came in at -$0.34 in Q1 2026, up 8.43% YoY from -$0.32 in Q1 2025, and up 21.16% on a QoQ basis from -$0.44 in Q3 2025.
Phio Pharmaceuticals (PHIO) EPS (Basic) (2011 - 2026) Analysis & Trends
Phio Pharmaceuticals (PHIO) has 16 years of EPS (Basic) data on file, last reported at -$0.34 in Q1 2026.
- Quarterly EPS (Basic) rose 8.43% year-over-year to -$0.34 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$0.75 (up 52.33% YoY) and the FY2024 annual result came in at -$9.78, up 83.07% from the prior year.
- EPS (Basic) improved to -$0.34 in Q1 2026, from -$0.44 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of -$0.01 in Q2 2023 to a low of -$28.65 in Q1 2023.
- A 5-year average of -$9.5 and a median of -$3.99 in 2024 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2023 — EPS (Basic) soared 99.93% — and 2024, when it sank 27775.42%.
- Tracing PHIO's EPS (Basic) over 5 years: stood at -$21.89 in 2022, then jumped by 64.36% to -$7.8 in 2023, then jumped by 72.1% to -$2.18 in 2024, then soared by 79.9% to -$0.44 in 2025, then rose by 21.16% to -$0.34 in 2026.
- The last three EPS (Basic) figures came in at -$0.34 (Q1 2026), -$0.44 (Q3 2025), and -$0.48 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 7.59 |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 2.12 |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.23 |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -0.06 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 0.18 |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -0.72 |
| 10 | Phio Pharmaceuticals | 14.06 Mn | 14.06 Mn | - | -0.36 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.36 |
| Mar 31, 2026 | -0.34 |
| Sep 30, 2025 | -0.44 |
| Jun 30, 2025 | -0.48 |
| Mar 31, 2025 | -0.38 |
| Dec 31, 2024 | -2.18 |
| Sep 30, 2024 | -1.54 |
| Jun 30, 2024 | -3.75 |
| Mar 31, 2024 | -4.24 |
| Dec 31, 2023 | -7.80 |
| Sep 30, 2023 | -10.37 |
| Jun 30, 2023 | -0.01 |
| Mar 31, 2023 | -28.65 |
| Dec 31, 2022 | -21.89 |
| Sep 30, 2022 | -28.50 |
| Jun 30, 2022 | -20.20 |
| Mar 31, 2022 | -21.28 |
| Dec 31, 2021 | -29.23 |
| Sep 30, 2021 | -30.19 |
| Jun 30, 2021 | -21.68 |